The Recall Desk
HighFDA (Drugs)·D-0576-2026·Announced 2026-06-10

Equaline extra strength antacid tablets contain small metallic particles

Equaline Extra Strength Antacid Tablets, calcium carbonate 750 mg, are being recalled because of the presence of small metallic particles in the chewable tablets.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: Metallic particles in a chewable tablet are a physical hazard capable of causing injury, a risk of harm with no injuries reported in the source.

Plain-English summary

EQUALINE Extra Strength Antacid Tablets, calcium carbonate 750 mg, 96 chewable tablets, distributed by SuperValu Inc. of Eden Prairie, Minnesota, NDC 41163-129-22, are being recalled.

The stated reason is the presence of a foreign substance: small metallic particles in the chewable tablets. The FDA classified the action as Class II.

The affected lot is 1276118, expiring January 2029. Distribution was USA nationwide.

Consumers who have the affected lot should stop using it and return it to the place of purchase. Anyone injured after taking the tablets should seek medical advice.

The recalled product

Product
EQUALINE EXTRA STRENGTH ASSORTED BERRY ANTACID (CALCIUM CARBONATE)
Brand
EQUALINE EXTRA STRENGTH ASSORTED BERRY ANTACID
Manufacturer
Guardian Drug Co. Inc.
Category
Drug — Antacid tablet
Hazard
  • foreign-object
  • metallic-particles
  • physical-hazard
  • class-ii
  • otc-drug

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 1276118
  • expires: JAN- 2029.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category